Sandbox:Javaria: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
<ref name="pmid22750769">{{cite journal |vauthors=Garg PK, Jain BK, Dubey IB, Sharma AK |title=Generalized lymphadenopathy: physical examination revisited |journal=Ann Saudi Med |volume=33 |issue=3 |pages=298–300 |date=2013 |pmid=22750769 |pmc=6078537 |doi=10.5144/0256-4947.2012.01.7.1525 |url=}}</ref><ref name="pmid24753638">{{cite journal |vauthors=Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A |title=Peripheral lymphadenopathy: approach and diagnostic tools |journal=Iran J Med Sci |volume=39 |issue=2 Suppl |pages=158–70 |date=March 2014 |pmid=24753638 |pmc=3993046 |doi= |url=}}</ref><ref name="pmid12484692">{{cite journal |vauthors=Bazemore AW, Smucker DR |title=Lymphadenopathy and malignancy |journal=Am Fam Physician |volume=66 |issue=11 |pages=2103–10 |date=December 2002 |pmid=12484692 |doi= |url=}}</ref>
<ref name="pmid22750769">{{cite journal |vauthors=Garg PK, Jain BK, Dubey IB, Sharma AK |title=Generalized lymphadenopathy: physical examination revisited |journal=Ann Saudi Med |volume=33 |issue=3 |pages=298–300 |date=2013 |pmid=22750769 |pmc=6078537 |doi=10.5144/0256-4947.2012.01.7.1525 |url=}}</ref><ref name="pmid24753638">{{cite journal |vauthors=Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A |title=Peripheral lymphadenopathy: approach and diagnostic tools |journal=Iran J Med Sci |volume=39 |issue=2 Suppl |pages=158–70 |date=March 2014 |pmid=24753638 |pmc=3993046 |doi= |url=}}</ref><ref name="pmid12484692">{{cite journal |vauthors=Bazemore AW, Smucker DR |title=Lymphadenopathy and malignancy |journal=Am Fam Physician |volume=66 |issue=11 |pages=2103–10 |date=December 2002 |pmid=12484692 |doi= |url=}}</ref><ref name="pmid10549745">{{cite journal |vauthors=Soldes OS, Younger JG, Hirschl RB |title=Predictors of malignancy in childhood peripheral lymphadenopathy |journal=J. Pediatr. Surg. |volume=34 |issue=10 |pages=1447–52 |date=October 1999 |pmid=10549745 |doi=10.1016/s0022-3468(99)90101-x |url=}}</ref><ref name="pmid10189390">{{cite journal |vauthors=Ghirardelli ML, Jemos V, Gobbi PG |title=Diagnostic approach to lymph node enlargement |journal=Haematologica |volume=84 |issue=3 |pages=242–7 |date=March 1999 |pmid=10189390 |doi= |url=}}</ref>
{{familytree/start |summary=Management of lymphadenopathy}}
{{familytree/start |summary=Management of lymphadenopathy}}
{{familytree | | | | | | | | | | | | | | Z01 | | | | | | | |Z01='''History'''<div class="mw-collapsible mw-collapsed"><div style="float: left; text-align: left; width: 20em; padding:1em;"><br><div style="float: left; text-align: left; width: 20em; padding:1em;">
{{familytree | | | | | | | | | | | | | | Z01 | | | | | | | |Z01='''History'''<div class="mw-collapsible mw-collapsed"><div style="float: left; text-align: left; width: 20em; padding:1em;"><br><div style="float: left; text-align: left; width: 20em; padding:1em;">
❑[[Patient]] [[age]] (specific demographic characteristics ([[age]]) of certain [[malignancy|malignancies]])<br>
:❑[[Patient]] [[age]] (specific demographic characteristics ([[age]]) of certain [[malignancy|malignancies]])<br>
❑ Duration of [[lymphadenopathy]] (<2 weeks or >1 year without an increase in size has low malignant potential)<br>
:❑ Duration of [[lymphadenopathy]] (<2 weeks or >1 year without an increase in size has low malignant potential)<br>
❑ Past medical history of underlying disease, suggestive of [[immunodeficiency]], or recurrent [[infections]]<br>
:❑ Past medical history of underlying disease, suggestive of [[immunodeficiency]], or recurrent [[infections]]<br>
❑ Sexual history suggestive of infection transmission<br>
:❑ Sexual history suggestive of infection transmission<br>
❑ Family history of certain malignant disorders ([[breast cancer]], or [[melanoma]])<br>
:❑ Family history of certain malignant disorders ([[breast cancer]], or [[melanoma]])<br>
❑ Exposure to communicable [[infectious disease]]s/ travel to high-risk areas<br>
:❑ Exposure to communicable [[infectious disease]]s/ travel to high-risk areas<br>
❑ Environmental exposure such as [[ultraviolet radiation|UV]] (skin cancer risk)/ animals/ occupational exposure <br>
:❑ Environmental exposure such as [[ultraviolet radiation|UV]] (skin cancer risk)/ animals/ occupational exposure <br>
❑ Social history such as tobacco use, alcohol use (head and neck cancers risk)<br>}}
:❑ Social history such as tobacco use, alcohol use (head and neck cancers risk)<br>
:❑ Associated symptoms such as [[pain]], [[fever]], [[weight loss]], [[anorexia]], [[cough]], or recurrent [[UTI]]s}}
{{familytree | | | | | | | | | | | | | | |!| | | | | | | }}
{{familytree | | | | | | | | | | | | | | |!| | | | | | | }}
{{familytree | | | | | | | | | | | | | | M01 | | | | | | | M01='''[[Physical exam]]'''<div class="mw-collapsible mw-collapsed"><div style="float: left; text-align: left; width: 20em; padding:1em;"><br>'''Appearance of the [[patient]]'''<br>[[Cachexia]] or surgical scar marks demonstrating previous malignancy treatment<br>
{{familytree | | | | | | | | | | | | | | M01 | | | | | | | M01='''[[Physical exam]]'''<div class="mw-collapsible mw-collapsed"><div style="float: left; text-align: left; width: 20em; padding:1em;"><br>'''Appearance of the [[patient]]'''<br>[[Cachexia]] or surgical scar marks demonstrating previous malignancy treatment<br>
[[Vital signs]]<br>
[[Vital signs]]<br>
*[[Temperature]]: High-grade / low-grade fever may demonstrate [[infection]]. <br>
:❑ [[Temperature]]: High-grade / low-grade fever may demonstrate [[infection]]. <br>
*[[Heart rate]]: [[Tachycardia]] with regular pulse may demonstrate [[infection]]. <br>
:❑ [[Heart rate]]: [[Tachycardia]] with regular pulse may demonstrate [[infection]]. <br>
*[[Respiratory rate]]: [[Tachypnea]] may demonstrate [[respiratory system]] involvement ([[infection]]\ [[metastasis]]).<br>
:❑ [[Respiratory rate]]: [[Tachypnea]] may demonstrate [[respiratory system]] involvement ([[infection]]\ [[metastasis]]).<br>
*[[Blood pressure]]: [[Chronic hypertension]] or [[hypotension]] (may indicate [[sepsis]] as a complication).<br>
:❑ [[Blood pressure]]: [[Chronic hypertension]] or [[hypotension]] (may indicate [[sepsis]] as a complication).<br>
*[[Oxygen saturation]]: may be low if the [[respiratory system]] is affected.}}
:❑ [[Oxygen saturation]]: may be low if the [[respiratory system]] is affected.<br>
❑ HEENT<br>
❑ [[Cardiovascular examination]]<br>
❑ [[Respiratory examination]]<br>
❑ [[Gastrointestinal system]] exam includes [[oral examination]], [[abdominal examination]], and [[digital rectal exam]]. <br>
:❑ [[Splenomegaly]]) may demonstrate [[infectious mononucleosis|IM]], [[Hodgkin's lymphoma|hodgkin's]]/ [[non-Hodgkin's lymphoma]], and [[sarcoidosis]]}}<br>
❑ [[Limb (anatomy)|Extremities]] exam<br>
❑ Skin exam: Evaluate for the lesions that indicate [[malignancy]] such as [[melanoma]]/ potential inoculation sites for germ such as traumatic lesions.}}
{{familytree | | | | | | | | | | | | | | |!| | | | | | |}}
{{familytree | | | | | | | | | | | | | | N01 | | | | | | | N01='''Palpable [[lymph node]]'''<div style="float: left; text-align: left; width: 20em; padding:1em;"><div class="mw-collapsible mw-collapsed"><br>
❑ Location: (Localized vs generalized)<br>
:❑ For nodes involving several groups of nodes; suspect malignancy.<br>
:❑ An enlarged node in a lymphatic rich region; suspect local disease.<br>
:❑ Associated red streaking, suspect [[lymphangitis]].<br>
:❑ Left [[supraclavicular lymph nodes|supraclavicular L.N]] ([[Virchow's nodes]]); suspect [[gastric carcinoma]]<br>
:❑ Right [[supraclavicular lymph nodes|supraclavicular L.N]], suspect intra-thoracic carcinoma<br>
❑ Dimensions <br>
The aforementioned dimensions are abnormal for a palpable [[lymph node]] but do not lead to the suspician of a [[neoplasm]].
:❑ [[Supraclavicular lymph nodes|supraclavicular]], [[iliac lymph nodes|iliac]], [[epitrochlear lymph nodes|epitrochlear]], and [[popliteal lymph nodes]] >0.5cm <br>
:❑ [[Inguinal nodes]] > 1.5 cm <br>
:❑ Other area [[lymph nodes]] >1 cm <br>
❑ Tenderness or pain: <br>
:❑ Suspect [[infection]]. <br>
:❑ A [[neoplastic]] node may also demonstrate [[pain]] due to [[hemorrhage]] associated with central necrosis or a brisk growing tumor.<br>
❑ Consistency <br>
:❑ Hard on palpation; suspect [[chronic inflammation]]<br>
:❑ consistent- acute inflammation<br>
:❑ Stony-hard and painless nodes-metastatic cancer/ [[granuloma]] <br>
:❑  Firm and rubbery nodes- lymphoma<br>
:❑ Matted [[lymph nodes|L.N]] suspect [[mycobacterium]] / [[sarcoidosis]]/ [[lymphoma]] / [[metastatic carcinoma]])<br>
❑ Mobility<br>
:❑ Freely movable; suspect [[infections]] and [[collagen vascular disease]]<br>
:❑ Fixed [[Lymph node|L.N]] to surrounding tissue; suspect [[malignancy]]}}.
{{familytree | | | | | | | | | | | | | | |!| | | | | | | }}
{{familytree | | | | | | | | | | | | | | |!| | | | | | | }}
{{familytree | | | | | | | | | | | | | |,|^|.| | | | | | |}}
{{familytree | | | | | | | | | | | | | |,|^|.| | | | | | |}}
Line 62: Line 95:
*Physical examination should not be missed as a finding may change the course of differential diagnosis. Missing the physical exam may lead to unnecessary investigations and unnecessary delays.<ref name="pmid22750769">{{cite journal |vauthors=Garg PK, Jain BK, Dubey IB, Sharma AK |title=Generalized lymphadenopathy: physical examination revisited |journal=Ann Saudi Med |volume=33 |issue=3 |pages=298–300 |date=2013 |pmid=22750769 |pmc=6078537 |doi=10.5144/0256-4947.2012.01.7.1525 |url=}}</ref>
*Physical examination should not be missed as a finding may change the course of differential diagnosis. Missing the physical exam may lead to unnecessary investigations and unnecessary delays.<ref name="pmid22750769">{{cite journal |vauthors=Garg PK, Jain BK, Dubey IB, Sharma AK |title=Generalized lymphadenopathy: physical examination revisited |journal=Ann Saudi Med |volume=33 |issue=3 |pages=298–300 |date=2013 |pmid=22750769 |pmc=6078537 |doi=10.5144/0256-4947.2012.01.7.1525 |url=}}</ref>
*Fine-needle aspiration biopsy (FNAC) or excisional biopsy is the gold standard for tissue diagnosis and evaluation for LAD.<ref name="pmid24753638">{{cite journal |vauthors=Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A |title=Peripheral lymphadenopathy: approach and diagnostic tools |journal=Iran J Med Sci |volume=39 |issue=2 Suppl |pages=158–70 |date=March 2014 |pmid=24753638 |pmc=3993046 |doi= |url=}}</ref>
*Fine-needle aspiration biopsy (FNAC) or excisional biopsy is the gold standard for tissue diagnosis and evaluation for LAD.<ref name="pmid24753638">{{cite journal |vauthors=Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A |title=Peripheral lymphadenopathy: approach and diagnostic tools |journal=Iran J Med Sci |volume=39 |issue=2 Suppl |pages=158–70 |date=March 2014 |pmid=24753638 |pmc=3993046 |doi= |url=}}</ref>
common causes
Lymphadenopathy involving [[supraclavicular lymph nodes|supraclavicular L.N]] poses the highest risk of [[malignancy]] (90% among patients >40 years of age) and 25% among < 40 years old. <ref name="pmid3049914">{{cite journal |vauthors=Fijten GH, Blijham GH |title=Unexplained lymphadenopathy in family practice. An evaluation of the probability of malignant causes and the effectiveness of physicians' workup |journal=J Fam Pract |volume=27 |issue=4 |pages=373–6 |date=October 1988 |pmid=3049914 |doi=10.1080/09503158808416945 |url=}}</ref>

Revision as of 13:28, 21 August 2020

[1][2][3][4][5]


Extremities exam
❑ Skin exam: Evaluate for the lesions that indicate malignancy such as melanoma/ potential inoculation sites for germ such as traumatic lesions.}}

.
 
 
 
 
 
 
 
 
 
 
 
 
 
History

Patient age (specific demographic characteristics (age) of certain malignancies)
❑ Duration of lymphadenopathy (<2 weeks or >1 year without an increase in size has low malignant potential)
❑ Past medical history of underlying disease, suggestive of immunodeficiency, or recurrent infections
❑ Sexual history suggestive of infection transmission
❑ Family history of certain malignant disorders (breast cancer, or melanoma)
❑ Exposure to communicable infectious diseases/ travel to high-risk areas
❑ Environmental exposure such as UV (skin cancer risk)/ animals/ occupational exposure
❑ Social history such as tobacco use, alcohol use (head and neck cancers risk)
❑ Associated symptoms such as pain, fever, weight loss, anorexia, cough, or recurrent UTIs
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Physical exam

Appearance of the patient
Cachexia or surgical scar marks demonstrating previous malignancy treatment

Vital signs

Temperature: High-grade / low-grade fever may demonstrate infection.
Heart rate: Tachycardia with regular pulse may demonstrate infection.
Respiratory rate: Tachypnea may demonstrate respiratory system involvement (infection\ metastasis).
Blood pressure: Chronic hypertension or hypotension (may indicate sepsis as a complication).
Oxygen saturation: may be low if the respiratory system is affected.

❑ HEENT
Cardiovascular examination
Respiratory examination
Gastrointestinal system exam includes oral examination, abdominal examination, and digital rectal exam.

Splenomegaly) may demonstrate IM, hodgkin's/ non-Hodgkin's lymphoma, and sarcoidosis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Palpable lymph node

❑ Location: (Localized vs generalized)

❑ For nodes involving several groups of nodes; suspect malignancy.
❑ An enlarged node in a lymphatic rich region; suspect local disease.
❑ Associated red streaking, suspect lymphangitis.
❑ Left supraclavicular L.N (Virchow's nodes); suspect gastric carcinoma
❑ Right supraclavicular L.N, suspect intra-thoracic carcinoma

❑ Dimensions
The aforementioned dimensions are abnormal for a palpable lymph node but do not lead to the suspician of a neoplasm.

supraclavicular, iliac, epitrochlear, and popliteal lymph nodes >0.5cm
Inguinal nodes > 1.5 cm
❑ Other area lymph nodes >1 cm

❑ Tenderness or pain:

❑ Suspect infection.
❑ A neoplastic node may also demonstrate pain due to hemorrhage associated with central necrosis or a brisk growing tumor.

❑ Consistency

❑ Hard on palpation; suspect chronic inflammation
❑ consistent- acute inflammation
❑ Stony-hard and painless nodes-metastatic cancer/ granuloma
❑ Firm and rubbery nodes- lymphoma
❑ Matted L.N suspect mycobacterium / sarcoidosis/ lymphoma / metastatic carcinoma)

❑ Mobility

❑ Freely movable; suspect infections and collagen vascular disease
❑ Fixed L.N to surrounding tissue; suspect malignancy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
{{{Y02 }}}
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
'❑
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient is unstable
 
 
 
 
Patient is stable
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
'
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
{{{ W02 }}}
 
{{{ W03 }}}
 
{{{ W04 }}}
 
{{{ W05 }}}
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S
 
{{{ V02 }}}
 
 
 
 
 
 
{{{ V04 }}}
 
{{{ V05 }}}
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
{{{ C01 }}}
 
 
 
 
 
 
 
 
 
 
 
 
{{{ C03 }}}
 
 
 
 
 
 
 
 
{{{C01}}}
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
{{{ M02 }}}
 
 
 
 
 
 
{{{ M03 }}}
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
{{{ H02 }}}
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
{{{ K02 }}}
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
{{{ I01 }}}
 
{{{ I02 }}}
 
 
 
 
 
 
{{{I01}}}
 
 

Do's

Patients with immunodeficiency should have a wide differential diagnosis consideringnon-Hodgkin's lymphoma and Kaposi’s sarcoma.[3]

Dont's

  • Physical examination should not be missed as a finding may change the course of differential diagnosis. Missing the physical exam may lead to unnecessary investigations and unnecessary delays.[1]
  • Fine-needle aspiration biopsy (FNAC) or excisional biopsy is the gold standard for tissue diagnosis and evaluation for LAD.[2]

common causes

Lymphadenopathy involving supraclavicular L.N poses the highest risk of malignancy (90% among patients >40 years of age) and 25% among < 40 years old. [6]

  1. 1.0 1.1 Garg PK, Jain BK, Dubey IB, Sharma AK (2013). "Generalized lymphadenopathy: physical examination revisited". Ann Saudi Med. 33 (3): 298–300. doi:10.5144/0256-4947.2012.01.7.1525. PMC 6078537. PMID 22750769.
  2. 2.0 2.1 Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A (March 2014). "Peripheral lymphadenopathy: approach and diagnostic tools". Iran J Med Sci. 39 (2 Suppl): 158–70. PMC 3993046. PMID 24753638.
  3. 3.0 3.1 Bazemore AW, Smucker DR (December 2002). "Lymphadenopathy and malignancy". Am Fam Physician. 66 (11): 2103–10. PMID 12484692.
  4. Soldes OS, Younger JG, Hirschl RB (October 1999). "Predictors of malignancy in childhood peripheral lymphadenopathy". J. Pediatr. Surg. 34 (10): 1447–52. doi:10.1016/s0022-3468(99)90101-x. PMID 10549745.
  5. Ghirardelli ML, Jemos V, Gobbi PG (March 1999). "Diagnostic approach to lymph node enlargement". Haematologica. 84 (3): 242–7. PMID 10189390.
  6. Fijten GH, Blijham GH (October 1988). "Unexplained lymphadenopathy in family practice. An evaluation of the probability of malignant causes and the effectiveness of physicians' workup". J Fam Pract. 27 (4): 373–6. doi:10.1080/09503158808416945. PMID 3049914.